Cue Biopharma (CUE) Receivables (2019 - 2025)
Historic Receivables for Cue Biopharma (CUE) over the last 7 years, with Q3 2025 value amounting to $387000.0.
- Cue Biopharma's Receivables fell 8772.21% to $387000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $387000.0, marking a year-over-year decrease of 8772.21%. This contributed to the annual value of $945000.0 for FY2024, which is 4434.63% down from last year.
- According to the latest figures from Q3 2025, Cue Biopharma's Receivables is $387000.0, which was down 8772.21% from $532000.0 recorded in Q2 2025.
- Cue Biopharma's Receivables' 5-year high stood at $3.2 million during Q3 2024, with a 5-year trough of $57000.0 in Q4 2022.
- In the last 5 years, Cue Biopharma's Receivables had a median value of $1.0 million in 2023 and averaged $1.3 million.
- In the last 5 years, Cue Biopharma's Receivables tumbled by 9818.62% in 2022 and then soared by 287894.74% in 2023.
- Quarter analysis of 5 years shows Cue Biopharma's Receivables stood at $3.1 million in 2021, then tumbled by 98.19% to $57000.0 in 2022, then skyrocketed by 2878.95% to $1.7 million in 2023, then tumbled by 44.35% to $945000.0 in 2024, then tumbled by 59.05% to $387000.0 in 2025.
- Its Receivables was $387000.0 in Q3 2025, compared to $532000.0 in Q2 2025 and $945000.0 in Q4 2024.